NLRP6 and colorectal cancer: Inosine, one of the upstream regulators of NLRP6-deficient CD103+ Bregs, can also be produced by the microbiota and is important in inhibition of severe autoimmunity (50), and improving the efficacy of checkpoint inhibitor therapy in colorectal cancer (51).